These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 3237251)

  • 1. On the 5-hydroxytryptamine transport across the plasma membrane of rabbit platelets and its inhibition by imipramine.
    Wölfel R; Böhm W; Halbrügge T; Bönisch H; Graefe KH
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Jul; 338(1):1-8. PubMed ID: 3237251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of imipramine and some tryptamine derivatives on the efflux of 3H-5-hydroxytryptamine from rabbit platelets.
    Wölfel R; Graefe KH
    J Neural Transm Suppl; 1991; 34():77-83. PubMed ID: 1817167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for various tryptamines and related compounds acting as substrates of the platelet 5-hydroxytryptamine transporter.
    Wölfel R; Graefe KH
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Feb; 345(2):129-36. PubMed ID: 1570019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-Hydroxytryptamine uptake and release in relation to aggregation of rabbit platelets.
    Baumgartner HR
    J Physiol; 1969 Apr; 201(2):409-23. PubMed ID: 5780550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Saturable uptake of [3H]-tryptamine in rabbit platelets is inhibited by 5-hydroxytryptamine uptake blockers.
    Segonzac A; Tateishi T; Langer SZ
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Nov; 328(1):33-7. PubMed ID: 6514017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temperature dependence of drug interaction with the platelet 5-hydroxytryptamine transporter: a clue to the imipramine selectivity paradox.
    Segonzac A; Schoemaker H; Langer SZ
    J Neurochem; 1987 Feb; 48(2):331-9. PubMed ID: 2947974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of N-ethylmaleimide on 5-hydroxytryptamine transport and sodium content in rabbit platelets.
    Wölfel R; Halbrügge T; Graefe KH
    Br J Pharmacol; 1989 Aug; 97(4):1308-14. PubMed ID: 2790384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uptake of 5-hydroxytryptamine in blood platelets and its inhibition by drugs: role of plasma membrane and granular storage.
    Laubscher A; Pletscher A
    J Pharm Pharmacol; 1979 May; 31(5):284-9. PubMed ID: 37296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of [3H]dihydrotetrabenazine and [125I]azidoiodoketanserin photoaffinity labeling of the monoamine transporter of platelet 5-HT organelles.
    Cesura AM; Bertocci B; Da Prada M
    Eur J Pharmacol; 1990 Sep; 186(1):95-104. PubMed ID: 2149340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-Methoxytryptoline, a competitive endocoid acting at [3H]imipramine recognition sites in human platelets.
    Segonzac A; Schoemaker H; Tateishi T; Langer SZ
    J Neurochem; 1985 Jul; 45(1):249-56. PubMed ID: 2987413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin uptake and imipramine binding in blood platelets and brain of Fawn-hooded and Sprague Dawley rats.
    Arora RC; Tong C; Jackman HL; Stoff D; Meltzer HY
    Life Sci; 1983 Aug; 33(5):437-42. PubMed ID: 6877030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics of the interaction of sertraline with the human platelet plasma membrane 5-hydroxytryptamine carrier.
    Phillips OM; Wood KM; Williams DC
    Eur J Pharmacol; 1988 Feb; 146(2-3):299-306. PubMed ID: 3371401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolated 5-hydroxytryptamine organelles of rabbit blood platelets: physiological properties and drug-induced changes.
    Da Prada M; Pletscher A
    Br J Pharmacol; 1968 Nov; 34(3):591-7. PubMed ID: 5726788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An assay to measure the simultaneous uptake of [3H]dopamine and [14C]serotonin by the human platelet reveals an imipramine-insensitive [3H]dopamine uptake mechanism.
    Dean B; Copolov DL
    Life Sci; 1992; 50(5):341-7. PubMed ID: 1732705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [3H]imipramine binding of protein nature in human platelets: inhibition by 5-hydroxytryptamine and 5-hydroxytryptamine uptake inhibitors.
    Marcusson J; Tiger G
    J Neurochem; 1988 Apr; 50(4):1032-6. PubMed ID: 3279163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endotoxin and dietary amines may increase plasma 5-hydroxytryptamine in the horse.
    Bailey SR; Cunningham FM; Elliott J
    Equine Vet J; 2000 Nov; 32(6):497-504. PubMed ID: 11093623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in [3H]5-HT uptake and [3H]imipramine binding in platelets after chlorimipramine in healthy volunteers. Comparison with maprotiline and amineptine.
    Poirier MF; Galzin AM; Loo H; Pimoule C; Segonzac A; Benkelfat C; Sechter D; Zarifian E; Schoemaker H; Langer SZ
    Biol Psychiatry; 1987 Mar; 22(3):287-302. PubMed ID: 3028514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelets and biogenic amines. 2. Indications for a discrete low affinity uptake mechanism shared by norepinephrine and 5-hydroxytryptamine in human platelets.
    Malmgren R
    Psychopharmacology (Berl); 1986; 90(3):384-9. PubMed ID: 3097728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allosteric interaction between the site labeled by [3H]imipramine and the serotonin transporter in human platelets.
    Meyerson LR; Ieni JR; Wennogle LP
    J Neurochem; 1987 Feb; 48(2):560-5. PubMed ID: 3491878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shape change and aggregation of blood platelets: interaction between the effects of adenosine and diphosphate, 5-hydroxytryptamine and adrenaline.
    Michal F; Motamed M
    Br J Pharmacol; 1976 Feb; 56(2):209-18. PubMed ID: 1252669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.